Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Tracon Pharmaceuticals, Inc. (TCON)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| Ikarian Capital, LLC reports a 12.5% stake in TRACON PHARMACEUTICALS, INC. |
| 02/10/2023 |
SC 13G/A
| aaronson wayne reports a 8.2% stake in Tracon Pharmaceuticals, Inc. |
| 02/14/2022 |
SC 13G/A
| Ikarian Capital, LLC reports a 13.8% stake in TRACON PHARMACEUTICALS, INC. |
| 01/27/2022 |
SC 13G/A
| Linden Capital L.P. reports a 4.6% stake in TRACON Pharmaceuticals, Inc. |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Ikarian Capital, LLC reports a 17.8% stake in TRACON PHARMACEUTICALS, INC. |
| 02/12/2021 |
SC 13G/A
| Opaleye Management Inc. reports a 17% stake in TRACON PHARMACEUTICALS, INC. |
| 02/09/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/14/2020 |
SC 13G/A
| Linden Capital L.P. reports a 9.9% stake in TRACON PHARMACEUTICALS, INC. |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2019 |
SC 13G/A
| Nextech III Oncology, LPCI reports a 1.6% stake in TRACON Pharmaceuticals, Inc. |
| 02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/29/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2018 |
SC 13G/A
| LYTTON LAURENCE W reports a 4.6% stake in TRACON Pharmaceuticals, Inc. |
| 02/13/2018 |
SC 13G/A
| JAFCO Super V3 Investment Limited Partnership reports a 4.5% stake in TRACON PHARMACEUTICALS, INC. |
| 02/12/2018 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 5.1% stake in TRACON Pharmaceuticals, Inc. |
| 02/05/2018 |
SC 13G/A
| FRANKLIN RESOURCES INC reports a 0% stake in TRACON Pharmaceuticals, Inc. |
| 01/22/2018 |
SC 13G/A
| JOHNSON & JOHNSON reports a 4.8% stake in TRACON Pharmaceuticals, Inc. |
| 02/13/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2016 |
SC 13G/A
| Nextech III Oncology, LPCI reports a 7.1% stake in TRACON Pharmaceuticals, Inc. |
| 02/09/2016 |
SC 13G/A
| JAFCO Super V3 Investment Limited Partnership reports a 12.3% stake in TRACON PHARMACEUTICALS, INC. |
|
|